This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies
Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Subscribe To Our Newsletter & Stay Updated
